Cargando…
Potential Role of Anti-Complement Agents in the Treatment of COVID-19-Related ARDS
Autores principales: | Spanopoulou, Christina, Kassimos, Dimitrios, Cassimos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656134/ https://www.ncbi.nlm.nih.gov/pubmed/33196010 http://dx.doi.org/10.31138/mjr.31.3.304 |
Ejemplares similares
-
The clinical role of echocardiography in severe COVID-related ARDS: Not just a technical tool
por: Lazzeri, Chiara, et al.
Publicado: (2021) -
Response to “Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19”
por: Mastellos, Dimitrios C., et al.
Publicado: (2021) -
COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021) -
ARDS in SARS: cytokine mediators and treatment implications
por: Salto-Tellez, Manuel, et al.
Publicado: (2005) -
Reply to Letter to the Editor: Therapeutic plasma exchange resolving COVID-19 related ARDS
por: Lin, Jui-Hsiang, et al.
Publicado: (2020)